产品名称
Opticap XL5 Durapore 0.22 µm 9/16 in.HB/HB, Opticap® XL 5, inlet connection diam. 9/16 in., cartridge nominal length 5 in. (12.5 cm)
material
PVDF
polypropylene
polypropylene housing
polypropylene support
polypropylene vent cap
silicone seal
reg. compliance
meets FDA Indirect Food Additive requirements cited in 21 CFR 177-182 (all component materials)
sterility
non-sterile
sterilization compatibility
autoclavable compatible
product line
Opticap® XL 5
feature
hydrophilic
manufacturer/tradename
Opticap®
parameter
≤6.6 mL/min air diffusion at 2.75 bar (40 psig) and 23 °C (in water)
1.0 bar max. differential pressure (15 psid) at 80 °C (Forward)
1.0 bar max. inlet pressure (15 psi) at 80 °C
2.8 bar max. inlet pressure (40 psi) at 60 °C
25 °C max. inlet temp.
3.4 bar max. differential pressure (50 psid) at 25 °C (Reverse; intermittent)
5.5 bar max. differential pressure (80 psid) at 25 °C (Forward)
5.5 bar max. inlet pressure (80 psi) at 23 °C
80 psig max. inlet pressure
technique(s)
sterile filtration: suitable
L
21.3 cm (8.4 in.)
cartridge nominal length
5 in. (12.5 cm)
diam.
14.5 cm (5.7 in.)
filtration area
0.35 m2
inlet connection diam.
9/16 in.
inlet to outlet W
21.3 cm (8.4 in.)
outlet connection diam.
9/16 in.
impurities
≤0.5 EU/mL bacterial endotoxins (LAL test, Aqueous extraction)
<0.5 EU/mL USP bacterial endotoxins (LAL test, sample aqueous extraction)
gravimetric extractables
≤15 mg/capsule
matrix
Durapore®
pore size
0.22 μm
input
sample type liquid
bubble point
≥3450 mbar (50 psig), air with water at 23 °C
fitting
1/4 in. drain/vent hose barb (with double O-ring Seal)
(14 mm (9/16 in.) Hose Barb Inlet and Outlet)
Quality Level
Analysis Note
按ASTM® F838方法进行细菌挑战,样品可截留1 x 10⁷ CFU/cm²以上浓度的缺陷短波单孢菌。
Disclaimer
General description
Other Notes
- 生物截留:微生物
- 作用机制:过滤(体积排阻)
- 应用:生物处理
- 预期用途:减少或去除微生物/生物负荷
- 使用说明:参见《Durapore® 滤膜过滤器润湿说明》用户手册
- 存储声明:干燥储存
- 处置声明:根据国家、省市和当地适用法规处置。
Packaging
Preparation Note
3次高压灭菌循环,每次60 min,126°C;不可在线蒸汽灭菌
Legal Information
相关内容
了解有关 mAb 最后过滤的更多信息,这是 mAb 加工的最后步骤,可确保为患者提供无菌药物。
Learn more about mAb final filtration, the last steps in mAb processing, which assure drug sterility for patients.
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持